Zobrazeno 1 - 10
of 692
pro vyhledávání: '"Alberico L, Catapano"'
Autor:
Monica Cattaneo, Andrea Baragetti, Alberto Malovini, Elena Ciaglia, Valentina Lopardo, Elena Olmastroni, Manuela Casula, Carolina Ciacci, Alberico L. Catapano, Annibale A. Puca
Publikováno v:
Immunity & Ageing, Vol 21, Iss 1, Pp 1-13 (2024)
Abstract Background Increased levels of pro-inflammatory proteins in plasma can be detected in older individuals and associate with the so called chronic low-grade inflammation, which contributes to a faster progression of aged-related cardiovascular
Externí odkaz:
https://doaj.org/article/a9fbdb58c7bc464a8d3e59a8816371b1
Publikováno v:
Pharmacological Research, Vol 196, Iss , Pp 106936- (2023)
Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of mortality and morbidity worldwide. Low-density lipoprotein cholesterol (LDL-C) is one of the most important causal factors for ASCVD. Based on the evidence of the clinical benefit
Externí odkaz:
https://doaj.org/article/aee0f1bcd51449b8861975dab247252a
Autor:
Julia Brandts, Sarah Bray, Guillermo Villa, Alberico L. Catapano, Neil R. Poulter, Antonio J. Vallejo-Vaz, Kausik K. Ray
Publikováno v:
The Lancet Regional Health. Europe, Vol 31, Iss , Pp 100665- (2023)
Summary: Background: The impact of the stepwise implementation of the 2019 European Society of Cardiology (ESC)/European Atherosclerosis Society (EAS) treatment algorithm on low-density lipoprotein cholesterol (LDL-C) goal attainment was simulated in
Externí odkaz:
https://doaj.org/article/d5519723bd9c486491d8b38aabbe1126
Autor:
Jamilah AlRahimi, Shukri AlSaif, Mirvat Alasnag, Zuhier Awan, Fawaz Almutairi, Hajer Al Mudaiheem, Baris Gencer, Alberico L Catapano, François Mach, Adel Tash
Publikováno v:
Heart Views, Vol 24, Iss 2, Pp 67-92 (2023)
Externí odkaz:
https://doaj.org/article/7a5b542f2e364aa8b9d9c1d891ad3002
Autor:
Marco Magnoni, Daniele Andreini, Angela Pirillo, Patrizia Uboldi, Roberto Latini, Alberico L. Catapano, Aldo P. Maggioni, Giuseppe D. Norata
Publikováno v:
Annals of Medicine, Vol 54, Iss 1, Pp 1036-1046 (2022)
Background HDL is endowed with several metabolic, vascular, and immunoinflammatory protective functions. Among them, a key property is to promote reverse cholesterol transport from cells back to the liver. The aim of this study was to estimate the as
Externí odkaz:
https://doaj.org/article/b4abe3cba5dc411b8276bc710d26c188
Publikováno v:
Frontiers in Genetics, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/fd4035352f38471e8a87b8250a494f11
Autor:
Kausik K. Ray, Inaam Haq, Aikaterini Bilitou, Marius C. Manu, Annie Burden, Carlos Aguiar, Marcello Arca, Derek L. Connolly, Mats Eriksson, Jean Ferrières, Ulrich Laufs, Jose M. Mostaza, David Nanchen, Ernst Rietzschel, Timo Strandberg, Hermann Toplak, Frank L.J. Visseren, Alberico L. Catapano
Publikováno v:
The Lancet Regional Health. Europe, Vol 29, Iss , Pp 100624- (2023)
Summary: Background: European data pre-2019 suggest statin monotherapy is the most common approach to lipid management for preventing cardiovascular (CV) events, resulting in only one-fifth of high- and very high-risk patients achieving the 2019 ESC/
Externí odkaz:
https://doaj.org/article/32912a0f3308464fa848f83c48aeb9b3
Autor:
Elena Olmastroni, Marta Gazzotti, Maurizio Averna, Marcello Arca, Patrizia Tarugi, Sebastiano Calandra, Stefano Bertolini, Alberico L. Catapano, Manuela Casula
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 10 (2023)
Background Evidence suggests that LPA risk genotypes are a possible contributor to the clinical diagnosis of familial hypercholesterolemia (FH). This study aimed at determining the prevalence of LPA risk variants in adult individuals with FH enrolled
Externí odkaz:
https://doaj.org/article/824df55f452e4ba28aff9a337cba2499
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: Major guidelines recommend the initiation of a beta-blocker therapy after an acute myocardial infarction (AMI). We aimed to map the treatment pathway of beta-blockers for AMI survivors during the first wave of COVID-19 pandemic in Italy a
Externí odkaz:
https://doaj.org/article/a6e636c24fb8431db62a764deb0aa8db
Autor:
Alberico L. Catapano MD, PhD, Michal Vrablik MD, PhD, Yuri Karpov MD, Baptiste Berthou Lic, Megan Loy BAppSc, Marie Baccara-Dinet MD
Publikováno v:
Journal of Cardiovascular Pharmacology and Therapeutics, Vol 27 (2022)
Objective: In primary hypercholesterolemia many people treated with statins do not reach their plasma LDL-C goals and are at increased risk of cardiovascular disease (CVD). This study aimed to evaluate efficacy and safety of a new fixed-dose combinat
Externí odkaz:
https://doaj.org/article/f986e251ef8d4cf39d6f4e9c6bb9ff7e